Re:Sinovac's vaccine efficacy less than 60% in Brazil trial ...
by ktln2 on Wednesday January 13, 2021 @10:31AM
(#25763186)
"In 1985, Mr. Yin, then 21, was the first to isolate the hepatitis A virus, and in 2001, he founded Sinovac Biotech ... From 2002 to 2011, Mr. Yin paid $77,000 to a senior Chinese drug regulator, Yin Hongzhang, and his wife to approve his vaccines, according to a 2018 filing to the Securities and Exchange Commission, citing court documents."
https://www.nytimes.com/2021/01/07/business/china-coronaviru...